MedTrace Logo

Serum Concentration of lgG in Patient With Acute Coronary Syndrome

NCT03394092 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-03-19

No results posted yet for this study

Summary

The aim of this study is to investigate the changes in glycopeptides of serum immunoglobulin G in patients with acute myocardial infarction and the relationships between its change and prognosis.

Conditions

  • Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

Quantitative measurements the changes of IgG glycosylation

Serum (50 each group) is obtained into ethylenediaminetetraacetic acid（EDTA） tubes from all subjects via antecubital venepuncture.Blood is obtained into ethylenediaminetetraacetic acid（EDTA） tubes from all subjects via antecubital venepuncture to assess the quantitative changes of IgG glycosylation by HPLC-MRM at 0 , 3 and 7 days after admission.

Sponsors & Collaborators

  • Dalian Institute of Chemical Physics, Chinese Academy of Sciences , Dalian

    collaborator UNKNOWN

  • The First Affiliated Hospital of Dalian Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2019-01-15
Completion
2019-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03394092 on ClinicalTrials.gov